Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2019
2019 World Conference on Lung Cancer
Access to all presentations that occur during the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2848
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
PR02 - Press Conference
- Type: Press Conference
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Coordinates: 9/08/2019, 09:45 - 10:30, CC7.1 A&B
-
+
PR02.04 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial (Now Available)
10:02 - 10:09 | Presenter: Naiyer A Rizvi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MS01 - Immunotherapy Resistance
- Type: Mini Symposium
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Moderators:Ignacio Gil-Bazo
- Coordinates: 9/08/2019, 10:30 - 12:00, San Francisco (2009)
-
+
MS01.02 - Treatment Determining Markers - What Have We Achieved so Far? (Now Available)
10:45 - 11:00 | Presenter: Naiyer A Rizvi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA03 - Systemic Therapies for SCLC: Novel Targets and Patients' Selection
- Type: Oral Session
- Track: Small Cell Lung Cancer/NET
- Presentations: 1
- Now Available
- Moderators:Christine Lee Hann
- Coordinates: 9/08/2019, 13:30 - 15:00, Hilton Head (1978)
-
+
OA03.07 - Immune-Related Adverse Events and Clinical Outcome to Anti PD-1 Axis Inhibition in SCLC: A Multicenter Retrospective Analysis (Now Available)
14:35 - 14:45 | Presenter: Biagio Ricciuti
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
YI04 - Basics of Immunology
- Type: Young Investigator Session
- Track: Young Investigators
- Presentations: 1
- Now Available
- Moderators:Noemi Reguart
- Coordinates: 9/08/2019, 13:30 - 15:00, Dublin (1997)
-
+
YI04.04 - How to Select Patients for Immunotherapy (Now Available)
14:30 - 14:50 | Presenter: Naiyer A Rizvi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA04 - Immuno Combinations and the Role of TMB
- Type: Oral Session
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Moderators:Solange Peters
- Coordinates: 9/08/2019, 15:15 - 16:45, Copenhagen (1980)
-
+
OA04.07 - Mutations Associated with Sensitivity or Resistance to Immunotherapy in mNSCLC: Analysis from the MYSTIC Trial (Now Available)
16:20 - 16:30 | Presenter: Naiyer A Rizvi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.01 - Advanced NSCLC
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
- Presentations: 0
- Coordinates: 9/09/2019, 10:15 - 18:15, Exhibit Hall
-
+
P2.01-01 - Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 ≥50%
10:15 - 10:15 | Author(s): Ahmet Sezer
- Abstract
Loading... -
+
P2.01-07 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1-Containing Therapy (HUDSON)
10:15 - 10:15 | Presenter: Si-Houy Lao-Sirieix
- Abstract
Loading...
-
+
MA11 - Immunotherapy in Special Populations and Predictive Markers
- Type: Mini Oral Session
- Track: Immuno-oncology
- Presentations: 1
- Now Available
- Moderators:Frank Griesinger
- Coordinates: 9/09/2019, 14:00 - 15:30, Hilton Head (1978)
-
+
MA11.11 - STK11/LKB1 Genomic Alterations Are Associated with Inferior Clinical Outcomes with Chemo-Immunotherapy in Non-Squamous NSCLC (Now Available)
15:10 - 15:15 | Author(s): Ferdinandos Skoulidis
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
